Increased UBE4B protein expression was also seen in tumors with non-amplified MYCN and in tumors from patients diagnosed at over 18 months of age, but these trends did not reach statistical significance (Figure 6E ).
← all excerpts
Neuroblastoma patient outcomes, tumor differentiation, and ERK activation are correlated with expression levels of the ubiquitin ligase UBE4B.
1
—
—